Mingjing Xu

Appearances

GENOME-WIDE CRISPR-CAS9 SCREENING IN PATIENT-DERIVED HEPATOCELLULAR CARCINOMA ORGANOID IDENTIFIES ESSENTIAL AND LENVATINIB RESISTANCE-ASSOCIATED GENES
Date
May 19, 2024
BACKGROUND: Hepatocellular carcinoma (HCC) is a significant contributor to global cancer-related mortality, with limited therapeutic options available for advanced-stage patients…
Presenter
Yue Guo
Speakers
Hua Xue
Mingjing Xu
Alissa Wong
Aikha Wong
Luyao Zhang
Hui Zhao
Xin Wang
Nathalie Wong
METHYLATION ANALYSIS OF RECURRENT HEPATOCELLULAR CARCINOMA
Date
May 19, 2024
BACKGROUND: Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths worldwide. Surgical resection remains the mainstay treatment for early localized HCC, but hepatic recurrence occurs in >70% of patients within 5-years post-surgery…
Presenter
Alissa Wong
Speakers
Dandan Pu
Xiaofan Ding
Mingjing Xu
Nathalie Wong